ardena news - Search News

Catalent to Sell Somerset Oral Solids Facility to Ardena

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset to Ardena

Reuters on MSN · 4d

Catalent to sell New Jersey facility

Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday. Catalent provides contract manufacturing services and performs fill-finish work,

Business Insider · 4d

Catalent To Sell Oral Solids Development Facility In Somerset, NJ To Ardena

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer

Seeking Alpha on MSN · 5d

Catalent to sell Somerset oral solids facility

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to contract manufacturer Ardena. Financial details of the agreement, which is expected to close in early 2025,

YAHOO!Finance · 5d

Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset,

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent

Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...

Zacks.com on MSN2d

Catalent Stock Flat Following the Sell Agreement With Ardena

CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

FiercePharma4d

Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

biopharma-reporter16d

Ardena debuts new nanomedicines facility at CPHI 2024

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...

5hon MSN

Carson's defense rises to challenge to hand Gardena a first loss

The Colts have three interceptions and don't give up a score on defense in picking up a key Marine League victory over the previously unbeaten Panthers.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results